
REGEN
The Regenerative Medicine and Genome Editing (REGEN) Program advances stem cell and genome-engineering approaches to model human disease and enable future regenerative therapies. REGEN provides investigators with the expertise, technologies, and collaborative support to apply these approaches across research areas.